LEADER 03711nam 2201105z- 450 001 9910595070503321 005 20231214133132.0 035 $a(CKB)5680000000080825 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/92154 035 $a(EXLCZ)995680000000080825 100 $a20202209d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBeta-Glucan in Foods and Health Benefits 210 $aBasel$cMDPI Books$d2022 215 $a1 electronic resource (194 p.) 311 $a3-0365-5107-7 311 $a3-0365-5108-5 330 $aThis Special Issue entitled ??-glucan in foods and health benefits? reports on the health benefits of indigestible carbohydrates with respect to metabolic diseases and immune functions. The effects of ?-glucan have been investigated through the use isolated preparations or natural dietary fibers from whole grain cereals and brans, yeasts, or Euglena. This Special Issue includes original research articles that are based on human intervention studies that address the effects of ?-glucan on metabolic diseases and immune function-related markers as well as in vitro and in vivo studies. It also reviews the health benefits of ?-glucans in humans. 606 $aResearch & information: general$2bicssc 606 $aBiology, life sciences$2bicssc 606 $aFood & society$2bicssc 610 $ahumans 610 $aoat ?-glucan 610 $aacute glycemic response 610 $adietary fiber 610 $apreload 610 $acarbohydrates 610 $a?-1,3-glucan 610 $aEuglena gracilis 610 $aCa2+ signaling 610 $aintestinal epithelial cell 610 $aintravital imaging 610 $asmall intestine 610 $aimmune system 610 $abarley 610 $a?-glucan 610 $amicroarray 610 $ashort chain fatty acids 610 $alipid metabolism. 610 $alow molecular weight 610 $afermentation 610 $aprebiotics 610 $aAutreobasidium pullulans 610 $a?-1,3-1,6-glucan 610 $aphysiological function 610 $aoat beta-glucan 610 $acolitis 610 $aCrohn's disease 610 $aapoptosis 610 $aautophagy 610 $aTLRs 610 $aDectin-1 610 $arats 610 $aL cell 610 $aglucagon-like peptide 1 (GLP-1) 610 $aglucose tolerance 610 $ashort-chain fatty acids 610 $asIgA 610 $amicrobiota 610 $arandomized clinical trial 610 $asymptoms 610 $agastrointestinal tract 610 $amusculo-skeletal system 610 $aoats 610 $aoatmeal 610 $abeta-glucan 610 $abeta glucan 610 $ahealth claim 610 $aregulation 610 $afood-health relationship 610 $agastritis 610 $ainflammatory process 610 $aantioxidant properties 610 $aparamylon 610 $aabdominal fat 610 $aDNA microarray 610 $agene ontology 610 $aPPAR signaling 615 7$aResearch & information: general 615 7$aBiology, life sciences 615 7$aFood & society 700 $aAoe$b Seiichiro$4edt$01332975 702 $aMorita$b Tatsuya$4edt 702 $aOhno$b Naohito$4edt 702 $aAoe$b Seiichiro$4oth 702 $aMorita$b Tatsuya$4oth 702 $aOhno$b Naohito$4oth 906 $aBOOK 912 $a9910595070503321 996 $aBeta-Glucan in Foods and Health Benefits$93041178 997 $aUNINA